tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Abbott narrows FY25 adjusted EPS view to $5.10-$5.20 from $5.05-$5.25

FY25 consensus $5.16. Abbott (ABT) projects full-year 2025 organic sales growth, excluding COVID-19 testing related sales, to be 7.5% to 8.0%, or 6.0% to 7.0% when including COVID-19 testing-related sales. FY25 revenue consensus $44.63B.

Elevate Your Investing Strategy:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1